Related Experiment Video
Updated: Aug 26, 2026
Surgical Treatment of an Endolymphatic Sac Tumor
Published on: May 26, 2023
Treatment of membranous Budd-Chiari syndrome: analysis of 480 cases
1Department of General Surgery, First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China. vl_institute1086@163.com
Background:
Budd-Chiari syndrome (BCS) presents a kind of disease resulted from the occlusion of hepatic vein and/or the intrahepatic inferior vena cava. Its different pathological types were proposed. According to our experience, the membranous type takes a large part of it, and we tried to explore the best treatment of membranous BCS through the analysis of 480 cases retrospectively.
Method:
The operative results of 480 patients with membranous BCS were analysed retrospectively.
Results:
Patients after Kimura's finger rupture, interventional treatment and membrane resection were followed up with rates of 84.62%, 86.55%, and 87.37%, respectively. The effective rates of the three methods were 61.4%, 91.7%, and 90.4%, respectively, and the recurrence rates of the disease after the 3 procedures were 38.6%, 8.3% and 9.6%, respectively. The long-term effects of interventional treatment and resection were significantly better than those of Kimura's finger rupture (P<0.05).
Conclusion:
Balloon dilatation is the choice for membranous BCS. Patients with extensive lesion, thick membrane or recurrence after percutaneous transhepatic angiography should undergo membrane resection.